Multi-physics simulations for investigating the effect of electrode conditions on transscleral ocular iontophoresis for particulate drug delivery into ocular tissues
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Sangjun | - |
dc.contributor.author | Kim, Se-Na | - |
dc.contributor.author | Lee, Chany | - |
dc.contributor.author | Choy, Young Bin | - |
dc.contributor.author | Im, Chang-Hwan | - |
dc.date.accessioned | 2024-02-21T06:30:13Z | - |
dc.date.available | 2024-02-21T06:30:13Z | - |
dc.date.issued | 2024-02 | - |
dc.identifier.issn | 2093-9868 | - |
dc.identifier.issn | 2093-985X | - |
dc.identifier.uri | http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/1146 | - |
dc.description.abstract | PurposeTransscleral ocular iontophoresis has been proposed to deliver charged particulate drugs to ocular tissues effectively by transmitting a weak electrical current through the sclera. The electric fields formed are influenced by the electrode conditions, thus affecting the amount of particulate drugs delivered to the ocular tissues via iontophoresis. Computational simulation is widely used to simulate drug concentrations in the eye; therefore, reflecting the characteristics of the drugs in living tissues to the simulations is important for a more precise estimation of drug concentration. In this study, we investigated the effect of electrode conditions (location and size) on the efficacy of transscleral iontophoresis.MethodsWe first determined the simulation parameters based on the comparison of the amount of drug in the sclera in the simulation and in vivo experimental results. The injection of the negatively charged nanoparticles into the cul-de-sac of the lower eyelid was simulated. The active electrode (cathode) was attached to the skin immediately above the injection site, while the return electrode (anode) was placed over the eyebrow. The drug concentration distribution in the eye, based on either the location or size of each electrode, was evaluated using the finite element method with the estimated simulation parameters.ResultsOur results indicate that drug permeability varies depending on the location and the size of the electrodes.ConclusionOur findings demonstrate that the determination of optimal electrode conditions is necessary to enhance the effectiveness of transscleral iontophoresis. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | SPRINGERNATURE | - |
dc.title | Multi-physics simulations for investigating the effect of electrode conditions on transscleral ocular iontophoresis for particulate drug delivery into ocular tissues | - |
dc.type | Article | - |
dc.publisher.location | 영국 | - |
dc.identifier.doi | 10.1007/s13534-024-00359-2 | - |
dc.identifier.scopusid | 2-s2.0-85184905718 | - |
dc.identifier.wosid | 001160034300001 | - |
dc.identifier.bibliographicCitation | BIOMEDICAL ENGINEERING LETTERS | - |
dc.citation.title | BIOMEDICAL ENGINEERING LETTERS | - |
dc.type.docType | Article; Early Access | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.relation.journalResearchArea | Engineering | - |
dc.relation.journalWebOfScienceCategory | Engineering, Biomedical | - |
dc.subject.keywordPlus | DEXAMETHASONE PHOSPHATE | - |
dc.subject.keywordPlus | FIELDS | - |
dc.subject.keywordPlus | RABBIT | - |
dc.subject.keywordPlus | EYE | - |
dc.subject.keywordAuthor | Ocular iontophoresis | - |
dc.subject.keywordAuthor | Transscleral drug delivery | - |
dc.subject.keywordAuthor | Finite element method | - |
dc.subject.keywordAuthor | Nernst-Planck equation | - |
dc.subject.keywordAuthor | Electrode condition | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
61, Cheomdan-ro, Dong-gu, Daegu, Republic of Korea , 41062 053-980-8114
COPYRIGHT Korea Brain Research Institute. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.